title: Incretin effect of glucagon-like peptide 1 receptor agonist is preserved in presence of ABCC8/SUR1 mutation in β-cell.
authors.forename: Olivier
authors.initials: O
authors.lastname: Bourron
authors.forename: Fatma
authors.initials: F
authors.lastname: Chebbi
authors.forename: Marine
authors.initials: M
authors.lastname: Halbron
authors.forename: Cécile
authors.initials: C
authors.lastname: Saint-Martin
authors.forename: Christine
authors.initials: C
authors.lastname: Bellanné-Chantelot
authors.forename: Ahmed
authors.initials: A
authors.lastname: Abed
authors.forename: Beny
authors.initials: B
authors.lastname: Charbit
authors.forename: Christophe
authors.initials: C
authors.lastname: Magnan
authors.forename: J M
authors.initials: JM
authors.lastname: Lacorte
authors.forename: Agnès
authors.initials: A
authors.lastname: Hartemann
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000235:genetics*; D000328:Adult; D003920:Diabetes Mellitus / Q000188:drug therapy; D000077270:Exenatide; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism; D000067757:Glucagon-Like Peptide-1 Receptor; D005951:Glucose Tolerance Test; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010455:Peptides / Q000627:therapeutic use; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D011955:Receptors, Drug / Q000235:genetics*; D018027:Receptors, Glucagon / Q000819:agonists*; D064233:Sulfonylurea Receptors; D014688:Venoms / Q000627:therapeutic use
chemical_list: C577507:ABCC8 protein, human; D018528:ATP-Binding Cassette Transporters; C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D054795:Incretins; D010455:Peptides; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D018027:Receptors, Glucagon; D064233:Sulfonylurea Receptors; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide